An introduction to gender-affirming hormone therapy for transgender and gender-nonbinary patients

The document provided an introduction to gender-affirming hormone therapy (GAHT) for transgender and gender-nonbinary (TGNB) patients, focusing on increasing healthcare providers' knowledge and competence in this area. It outlined the importance of cultural competence, the informed consent model (ICM) of care, and appropriate GAHT treatments and diagnostic testing. The article included case scenarios to help practitioners apply their knowledge, such as prescribing testosterone gel for a TGNB patient assigned female at birth and discussing the effects and monitoring of GAHT. The document aimed to ensure that 75% of participants could demonstrate increased knowledge by achieving a posttest score of 70% or greater.